Oesch, Lisa
Arnold, Marcel
Bernasconi, Corrado
Kaesmacher, Johannes
Fischer, Urs
Mosimann, Pascal J.
Jung, Simon
Meinel, Thomas
Goeldlin, Martina
Heldner, Mirjam
Volbers, Bastian
Gralla, Jan
Sarikaya, Hakan
Funding for this research was provided by:
Schweizerische Herzstiftung
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Stryker
Pfizer
Bayer
Article History
Received: 7 February 2020
Revised: 13 July 2020
Accepted: 17 August 2020
First Online: 31 August 2020
Compliance with ethical standards
:
: Unrelated: Professor Gralla is a global PI of STAR, CEC member of the PROMISE study (Penumbra) PI for the SWIFT DIRECT study (Medtronic), Consultancy; and receives SNSF grants for magnetic resonance imaging in stroke. Professor Fischer is a global PI for the SWIFT DIRECT study (Medtronic) and receives research grants from Swiss National Science Foundation (SNSF). Dr. Mosimann receives research grants from Swiss National Science Foundation (SNSF) to study new therapeutic options for cerebral aneurysms and cerebral vasospasm. Mr. Kaesmacher received travel support by Stryker and Pfizer. Dr. Volbers reports personal fees from Pfizer AG/Bristol-Myers Squibb SA, personal fees from Bayer AG, and grants from Institutional grant (Inselspital) outside the submitted work. All other authors have nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.